Company: FCRS
Filing Date: 2025-09-29
Form Type: 8-K
Source: 0001213900-25-093171
Chunk: 1

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-09-29
Form: 8-K
Item: Item 1.01
Chunk 1
---
───────────────────────

  A Registration Rights Agreement, dated September 25, 2025, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by r...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  A Private Placement Warrants Purchase Agreement, dated September 25, 2025 (the “ Sponsor Private Placement Warrants Purchase Agreement ”), by and between the Company and FutureCrest Acquisition...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  A Private Placement Warrants Purchase Agreement, dated September 25, 2025 (the “ Representative Private Placement Warrants Purchase Agreement ”), by and between the Company and the Representati...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  A Letter Agreement, dated September 25, 2025 (the “ Letter Agreement ”), by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.5 heret...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Indemnity Agreements, dated September 25, 2025 (each, an “ Indemnity Agreement ”), by and among the Company and each director and executive officer of the Company, a form of which is attached a...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

The material terms of such
agreements are fully described in the Company’s final prospectus, dated September 25, 2025, as filed with the Commission on September
26, 2025 (the “ Prospectus”) and are incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity
Securities.

Simultaneously with the closing
of the IPO, pursuant to the Sponsor Private Placement Warrants Purchase Agreement and the Representative Private Placement Warrants Purchase
Agreement, the Company completed the private sale of an aggregate of 3,500,000 warrants (the “ Private Placement Warrants